Enhancer demethylation-regulated gene score identified molecular subtypes, inspiring immunotherapy or CDK4/6 inhibitor therapy in oesophageal squamous cell carcinoma

Wenyan Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhihua Liu(California Institute of Technology)

EBioMedicine

June 25, 2024

10.1016/j.ebiom.2024.105177

Cited by 9

Related Papers

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma

|JAMA|2021|821

A Phase III, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer – The FALUCA study

|Lung Cancer|2020|21